logo munafa.co.com

NEWS Gainers Losers
 Learn then Earn

 story : Moderna reports .7 billion in COVID-19 vaccine sales, posts first profit ever #FinanceUSA #StockMarketNEWS Moderna Inc. brought in .7 billion in sales of its COVID-19 vaccine in the first quarter

@stockMarketNEWS Thu 06 May, 2021

Posted in: #FinanceUSA #StockMarketNEWS

Moderna reports .7 billion in COVID-19 vaccine sales, posts first profit ever #FinanceUSA #StockMarketNEWS
Moderna Inc. brought in .7 billion in sales of its COVID-19 vaccine in the first quarter of 2021, marking the company's first significant billion-dollar revenue haul this year and also the first time it's ever reported a GAAP profit. Moderna had earnings of .2 billion, or .84 per share, in the first quarter of 2021. This is compared to a loss of 4 million, or 35 cents per share, in the first quarter a year ago. The FactSet consensus was .39. Moderna had revenue of .9 billion for the quarter, up from million in the same quarter a year ago. The FactSet consensus for revenue was .0 billion. This quarter marked the first time that the company has generated product revenue during the first three months of the year. About .7 billion of that came from sales of its COVID-19 vaccine. (Before receiving authorization from the Food and Drug Administration, it generated grant and collaboration revenue.) Moderna's stock is up 55.8% for the year, while the S&P 500 has gained 10.9%.


Munafa USA Munafa India Munafa NSE


Report

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

 Learn then Earn
Back to top | Use Dark Theme